Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Designing antibodies as therapeutics
Paul J. Carter, Arvind Rajpal
Cell (2022) Vol. 185, Iss. 15, pp. 2789-2805
Open Access | Times Cited: 124

Showing 1-25 of 124 citing articles:

The Dawn of a New Era: Targeting the “Undruggables” with Antibody-Based Therapeutics
Linghui Qian, Xuefen Lin, Xue Gao, et al.
Chemical Reviews (2023) Vol. 123, Iss. 12, pp. 7782-7853
Closed Access | Times Cited: 60
Extracellular targeted protein degradation: an emerging modality for drug discovery
James A. Wells, Kaan Kumru
Nature Reviews Drug Discovery (2023) Vol. 23, Iss. 2, pp. 126-140
Closed Access | Times Cited: 43
Nuclear-import receptors as gatekeepers of pathological phase transitions in ALS/FTD
Bilal Khalil, Miriam Linsenmeier, Courtney L. Smith, et al.
Molecular Neurodegeneration (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 12
Approaches to expand the conventional toolbox for discovery and selection of antibodies with drug-like physicochemical properties
Hristo L. Svilenov, Paolo Arosio, Tim Menzen, et al.
mAbs (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 22
Artificial intelligence in cancer immunotherapy: Applications in neoantigen recognition, antibody design and immunotherapy response prediction
Li Tong, Yupeng Li, Xiaoyi Zhu, et al.
Seminars in Cancer Biology (2023) Vol. 91, pp. 50-69
Closed Access | Times Cited: 21
Automated optimisation of solubility and conformational stability of antibodies and proteins
Angelo Rosace, Anja Bennett, Marc Oeller, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 19
Variable domain mutational analysis to probe the molecular mechanisms of high viscosity of an IgG 1 antibody
Jing Dai, Saeed Izadi, Jonathan Zarzar, et al.
mAbs (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 11
Reprogramming natural killer cells for cancer therapy
Kexin Wang, Linqin Wang, Yiyun Wang, et al.
Molecular Therapy (2024) Vol. 32, Iss. 9, pp. 2835-2855
Closed Access | Times Cited: 8
Selective haematological cancer eradication with preserved haematopoiesis
Simon Garaudé, Romina Marone, Rosalba Lepore, et al.
Nature (2024) Vol. 630, Iss. 8017, pp. 728-735
Open Access | Times Cited: 8
Myricetin Oligomer Triggers Multi-Receptor Mediated Penetration and Autophagic Restoration of Blood-Brain Barrier for Ischemic Stroke Treatment
Lei Liu, Zhifang Ma, Qiaoyi Han, et al.
ACS Nano (2024) Vol. 18, Iss. 14, pp. 9895-9916
Closed Access | Times Cited: 6
Regulatory considerations in the design, development and quality of monoclonal antibodies and related products for the diagnosis and treatment of cancer
Marjorie A. Shapiro
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 6
Nuclease-assisted selection of slow-off rate aptamers
Obtin Alkhamis, Juan Canoura, Linlin Wang, et al.
Science Advances (2024) Vol. 10, Iss. 24
Open Access | Times Cited: 6
Prediction of protein biophysical traits from limited data: a case study on nanobody thermostability through NanoMelt
Aubin Ramon, Mingyang Ni, Olga Predeina, et al.
mAbs (2025) Vol. 17, Iss. 1
Open Access
Decoupling Individual Host Response and Immune Cell Engager Cytotoxic Potency
Cristina Gonzàlez Gutierrez, Adrien Aimard, Martine Biarnes‐Pelicot, et al.
ACS Nano (2025)
Open Access
Introduction
Keisuke Aoki
Springer theses (2025), pp. 1-9
Closed Access
Construction and characterization of chimeric FcγR T cells for universal T cell therapy
Juanjuan Zhao, Manling Chen, Xudong Li, et al.
Experimental Hematology and Oncology (2025) Vol. 14, Iss. 1
Open Access
AACDB: Antigen-Antibody Complex Database — a Comprehensive Database Unlocking Insights into Interaction Interface
Yuwei Zhou, Wenwen Liu, Ziru Huang, et al.
(2025)
Open Access
AACDB: Antigen-Antibody Complex Database — a Comprehensive Database Unlocking Insights into Interaction Interface
Yuwei Zhou, Wenwen Liu, Ziru Huang, et al.
(2025)
Open Access
Isolation of PCSK9-specific nanobodies from synthetic libraries using a combined protein selection strategy
Apisitt Thaiprayoon, Yodpong Chantarasorn, Worrapoj Oonanant, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Complete primer set for amplification and expression of full-length recombinant human monoclonal antibodies from single human B cells
Sachin Kushwaha, Varsha Jawahar, Ajay Kumar, et al.
Journal of Immunological Methods (2025), pp. 113823-113823
Closed Access
Epitope-engineered human hematopoietic stem cells are shielded from CD123-targeted immunotherapy
Romina Marone, Emmanuelle Landmann, Anna Devaux, et al.
The Journal of Experimental Medicine (2023) Vol. 220, Iss. 12
Open Access | Times Cited: 18
Optimization of therapeutic antibodies for reduced self-association and non-specific binding via interpretable machine learning
Emily K. Makowski, Tiexin Wang, Jennifer M. Zupancic, et al.
Nature Biomedical Engineering (2023) Vol. 8, Iss. 1, pp. 45-56
Closed Access | Times Cited: 17
AI models for protein design are driving antibody engineering
Michael Chungyoun, Jeffrey J. Gray
Current Opinion in Biomedical Engineering (2023) Vol. 28, pp. 100473-100473
Open Access | Times Cited: 16
Subcutaneous Administration of Monoclonal Antibodies: Pharmacology, Delivery, Immunogenicity, and Learnings From Applications to Clinical Development
John D. Davis, Marçal Bravo Padros, Daniela J. Conrado, et al.
Clinical Pharmacology & Therapeutics (2023) Vol. 115, Iss. 3, pp. 422-439
Open Access | Times Cited: 16
NKp46 ‐specific single domain antibodies enable facile engineering of various potent NK cell engager formats
Britta Lipinski, Paul Arras, Lukas Pekar, et al.
Protein Science (2023) Vol. 32, Iss. 3
Open Access | Times Cited: 15
Page 1 - Next Page

Scroll to top